The XI Liquid Biopsy Symposium (Santiago de Compostela)
In January 2026, the XI Liquid Biopsy Symposium in Santiago de Compostela served as a critical platform for international and domestic advancements.
Global Collaboration: The symposium featured leaders from the European Liquid Biopsy Society (ELBS), highlighting Spain's role in international initiatives for early cancer detection and Minimal Residual Disease (MRD) monitoring.
Key Focus Areas: Discussions centered on the clinical implementation of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) as standard tools for real-time monitoring of tumor evolution.
Recognition: The event awarded research with the highest scores, emphasizing Spain's commitment to fostering a high-quality scientific community in the liquid biopsy space.
1 View
